Nuvectis Pharma had a nice pop today and is currently up 4.39% we'll see if the cash keeps flowing in.
The company isn't at an immediate support or resistance level that might be predictive. But let's also consider momentum! Nuvectis Pharma has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the asset has grown 173.68 percent which isn't too bad. NVCT might find some support at the 11.85 level, buyers might push the price back up from here. But it's not very clear what will happen.
